RTI’s latest deal: Joining NovaQuest in acquisition of Clinical Ink
RTI International is making its second investment of the spring, joining Raleigh-based NovaQuest Capital Management in acquiring clinical trials tech firm Clinical Ink.
Read More
clinical trials software
Winston-Salem’s Clinical Ink is raising $2.5 million (+ video)
Clinical Ink, which focuses on software for clinical trials, is raising more cash from investors.
Read More
